CPIX250417C7500
- 0.20
- 0.000.00%
Cumberland Pharmaceuticals Newsroom
Trump Says 'Major Tariff on Pharmaceuticals' Coming Soon
Investors Don't See Light At End Of Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Tunnel And Push Stock Down 26%
12 Health Care Stocks Moving In Friday's After-Market Session
Cumberland Pharmaceuticals Announced Results From Its Phase 2 FIGHT DMD Clinical Trial Were Selected For Late-breaking Presentation At The Muscular Dystrophy Association Clinical & Scientific Conference In Dallas
Express News | Fight Dmd Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference
FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Cumberland Pharmaceuticals | 10-K: FY2024 Annual Report
$CPIX Stock Is up 14% Today. Here's What We See in Our Data.
Cumberland Pharmaceuticals Shares Are Trading Lower. The Company Reported Q4 Financial Results.
Express News | Cumberland Pharmaceuticals Shares Are Trading Lower. The Company Reported Q4 Financial Results
Earnings Call Summary | Cumberland Pharmaceuticals(CPIX.US) Q4 2024 Earnings Conference
Express News | Cumberland Q4 Adj EPS $(0.02) Up From $(0.11) YoY, Sales $10.44M Up From $9.35M YoY
Express News | Cumberland Pharmaceuticals Q4 Net Income USD -1.9 Million
Cumberland Pharma 4Q Loss/Shr 14c >CPIX
Press Release: Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth
Earnings Scheduled For March 4, 2025
Glenmark Pharmaceuticals Inc., USA Acquires and Launches Acetylcysteine Injection, 6 Gm/30 ML (200 Mg/mL) Single-Dose Vials
Cumberland Pharmaceuticals (CPIX.US) will release its Earnings Reports after the market closes on March 4.
$ Cumberland Pharmaceuticals (CPIX.US) $ will release its Earnings Reports after the market closes on March 4th, investors please pay attention. How was the previous performance? $ Cumberland Pharmaceuticals (CPIX.US) $ 2024 Q3 revenue is 9.0858 million USD, Net income is -1.537 million USD, EPS is -0.11 USD. 2023 Q4 revenue is 9.3531 million USD, Net income is -6.302 million USD, EPS is -0.44 USD. The accounting standards used for the above data are US_GAAP. Futubull reminds: 1. The accounting year division time for Hong Kong and US listed companies.